Mitochondria are dynamic organelles central to energy production, cellular metabolism, and signaling, and current research is reshaping how they are understood in health and disease.

They generate ATP through oxidative phosphorylation, but this process also produces reactive oxygen species, which at controlled levels act as signaling molecules and at excess levels trigger damage and cell death. Mitochondria help regulate apoptosis through proteins in the outer membrane and the release of cytochrome c, linking them closely to cancer, neurodegeneration, and immune responses.

Their own small circular genome encodes a handful of essential proteins. Mutations or deletions in this DNA, or in nuclear genes required for mitochondrial function, cause a wide range of mitochondrial diseases that often affect energy demanding tissues such as brain, heart, and muscle. Research is clarifying how defective oxidative phosphorylation, altered dynamics, and impaired quality control drive these conditions.

Mitochondria constantly fuse and divide. Fusion helps mix contents and dilute damage, while fission isolates defective segments and facilitates their removal. Specialized pathways recognize damaged mitochondria and eliminate them through mitophagy. Disruption of these processes is implicated in aging and disorders such as Parkinson disease, where accumulation of dysfunctional mitochondria and impaired clearance are key themes.

Recent work highlights mitochondria as hubs for innate immunity and inflammatory signaling, with mitochondrial DNA and metabolites acting as danger signals. Investigators are exploring therapeutic strategies including targeting bioenergetics, modulating dynamics and mitophagy, and using mitochondrial replacement or gene therapies to correct inherited defects.